l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to The gut–brain axis and trimethylamine
The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review Trimethylamine N Oxide in Relation to Cardiometabolic HealthCause or Effect? JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




